None listed
Conditions
Interventions
Procedure/Surgery : This is a pragmatic randomized controlled trial, and the physicians will select the specific type and doses of treatment, in the manner of pharmacopuncture or conservative treatmen
Sponsors
Jaseng Medical Foundation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Patients with neck pain persisting for more than 3 months ? Patients with a Numeric Rating Scale (NRS) score of 5 or higher for neck pain ? Patients aged between 19 and 70 years ? Patients who agree to participate in the clinical study and provide a written informed consent form
Exclusion criteria
Exclusion criteria: ? Patients diagnosed with serious specific diseases that could be the cause of neck pain (e.g., spinal metastasis of tumors, acute fractures, and spinal dislocations) ? Patients exhibiting progressive neurological deficits or severe neurological symptoms ? Patients whose pain originates from soft tissue disorders rather than the spine (e.g., tumors, fibromyalgia, rheumatoid arthritis, gout) ? Patients with other chronic diseases that could interfere with the interpretation of treatment effects or outcomes (e.g., stroke, myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy) ? Patients currently taking steroids, immunosuppressants, psychiatric medications, or other drugs that could affect the study results ? Patients for whom pharmacopuncture treatment is inappropriate or unsafe: those with bleeding disorders, those undergoing anticoagulant therapy, and severe diabetic patients with infection risks ? Patients who have taken medications that could affect pain (e.g., Non-Steroidal Anti-Inflammatory Drugs, NSAIDs) or received pharmacopuncture, acupuncture, or physical therapy within the past week ? Pregnant women, those planning to become pregnant, or those currently breastfeeding ? Patients who have undergone cervical spine surgery within the past 3 months ? Patients who have not completed participation in another clinical study within the past month or plan to participate in another clinical study during the study participation and follow-up period within 6 months from the date of selection ? Patients who find it difficult to provide informed consent for participation ? Other cases where the researcher deems participation in the clinical study to be difficult
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neck pain Numeric Rating Scale, NRS | — |
Secondary
| Measure | Time frame |
|---|---|
| Neck and arm pain Numeric Rating Scale;Neck and arm pain Visual Analogue Scale;Northwick Park Questionnaire;Neck disability index;Patient Global Impression of Change;Health-related Quality of Life Instrument with 8 Items;5-Level EuroQol-5 Dimension ;Adverse events | — |
Countries
Korea, Republic of
Contacts
Public ContactJu Yeon Kim
Jaseng Medical Foundation
Outcome results
None listed